Sugi Predict

Sugi Predict / Compounds / SCHEMBL1445683

SCHEMBL1445683

SCHEMBL1445683

c1ccc2c(CC3CCCN3)c[nH]c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 14/20 1.00
▸ HTR2A P28223 3/20 0.67
▸ SLC6A4 P31645 1/20 0.61
▸ HTR1A P08908 2/20 0.54
▸ HTR1B P28222 2/20 0.54
▸ HTR2C P28335 2/20 0.54
▸ HTR1F P30939 2/20 0.54
▸ HTR1D P28221 1/20 0.54
▸ HTR7 P34969 1/20 0.54
▸ GABRP O00591 1/20 0.51
▸ GABRD O14764 1/20 0.51
▸ GABRA1 P14867 1/20 0.51
▸ GABRB1 P18505 1/20 0.51
▸ GABRG2 P18507 1/20 0.51
▸ GABRB3 P28472 1/20 0.51
▸ GABRA5 P31644 1/20 0.51
▸ GABRA3 P34903 1/20 0.51
▸ GABRA2 P47869 1/20 0.51
▸ GABRB2 P47870 1/20 0.51
▸ GABRA4 P48169 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30675329 1.00 HTR6 (1.00) HTR6HTR2ASLC6A4HTR1AHTR1B
SCHEMBL31403 1.00 HTR6 (1.00) HTR6HTR2ASLC6A4HTR1AHTR1B
SCHEMBL30898 1.00 HTR6 (1.00) HTR6HTR2ASLC6A4HTR1AHTR1B
SCHEMBL8790419 0.95 HTR6 (0.91) HTR6HTR2ASLC6A4HTR1AHTR1B
SCHEMBL30675328 0.85 HTR6 (0.74) HTR6HTR2ASLC6A4MEN1CYP3A4
SCHEMBL24178288 0.82 HTR6 (0.69) HTR6HTR2ASLC6A4HTR1BHTR2C
SCHEMBL24178316 0.82 HTR6 (0.69) HTR6HTR2ASLC6A4HTR1BHTR2C
SCHEMBL30361714 0.82 HTR6 (0.69) HTR6HTR2ASLC6A4HTR1BHTR2C
SCHEMBL12244120 0.81 HTR6 (0.68) HTR6HTR2AHTR1AHTR1BHTR2C
SCHEMBL23802829 0.81 HTR6 (0.68) HTR6HTR2ASLC6A4HTR1BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383850-A1 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO MINDSET PHARMA INC. (CA) 2024-11-21 — — US disclosed
EP-4301747-A1 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. (CA) 2024-01-10 — — EP disclosed
WO-2022183288-A1 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO MINDSET PHARMA INC. (CA) 2022-09-09 — — WO disclosed
US-20170283781-A1 BIOCATALYSTS AND METHODS FOR SYNTHESIZING DERIVATIVES OF TRYPTAMINE AND TRYPTAMINE ANALOGS INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2017-10-05 — — US disclosed
US-9708588-B2 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs CODEXIS, INC. (US) 2017-07-18 — — US disclosed
US-20160289649-A1 BIOCATALYSTS AND METHODS FOR SYNTHESIZING DERIVATIVES OF TRYPTAMINE AND TRYPTAMINE ANALOGS INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2016-10-06 — — US disclosed
US-9388395-B2 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs CODEXIS, INC. (US) 2016-07-12 — — US disclosed
US-9271971-B2 Pyrido[3,4-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-03-01 — — US disclosed
US-9271971-B2 Pyrido[3,4-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-03-01 — — US disclosed
US-20150352087-A1 PYRIDO[3,4-B]INDOLES AND METHODS OF USE MEDIVATION TECHNOLOGIES, INC. 2015-12-10 — — US disclosed
CN-1136432-A Indole derivatives PFIZER (US) 1996-11-27 — — CN disclosed
US-5578612-A Indole derivatives PFIZER INC. (US) 1996-11-26 — — US disclosed
US-5559129-A SEROTONIN (5HT1) ANTAGONIST FOR TREATMENT OF DEPRESSION, ANXIETY, EATING DISORDERS, OBESITY, DRUG ABUSE, HEADACHES, AND PAIN PFIZER INC (US) 1996-09-24 — — US disclosed
US-5559246-A PROCESS OF DEHYDROHALOGENATION FOR CYCLIZATION TO PRODUCE PSYCHOTHERAPEUTIC AGENTS AND ANTISEROTONIN ANTAGONIST PFIZER INC. (US) 1996-09-24 — — US disclosed
US-5545644-A SEROTONIN AGONISTS; HYPOTENSIVE AND ANXIOLYTIC AGENTS; ANALGESICS; ANTIDEPRESSANTS; EATING DISORDERS; DRUG ABUSE; HEADACHES; VASCULAR DISORDERS PFIZER INC. (US) 1996-08-13 — — US disclosed
EP-0635017-A1 INDOLE DERIVATIVES AS 5-HT1 AGONISTS PFIZER INC. (US) 1995-01-25 — — EP disclosed
EP-0592438-A1 INDOLE DERIVATIVES. PFIZER (US) 1994-04-20 — — EP disclosed
WO-1993020073-A1 INDOLE DERIVATIVES AS 5-HT1 AGONISTS PFIZER INC. (US) 1993-10-14 — — WO disclosed
WO-1993018032-A1 INDOLE DERIVATIVES AS 5-HT1 AGONISTS PFIZER INC. (US) 1993-09-16 — — WO disclosed
WO-1992006973-A1 INDOLE DERIVATIVES PFIZER INC. (US) 1992-04-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383850-A1 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO TPH1, HTR5A, TPH2 HTR6 6/4885HTR2A 7/4885SLC6A4 18/4885
US-20150352087-A1 PYRIDO[3,4-B]INDOLES AND METHODS OF USE HTR3B, HTR4, HTR2C HTR6 10/4885HTR2A 12/4885SLC6A4 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.